Filing Flows

Filing Flows › 8-K events › Sanuwave Health

Sanuwave Health: entry into a material definitive agreement

Form 8-K filed Oct 28, 2026 · items 1.01

What the filing says

On October 28, 202 6, Sanuwave Health, Inc., a Nevada corporation (the “Company”), entered into Amendment No. 1 to Credit Agreement and Waiver (the “Amendment”) to the credit agreement (the “Credit Agreement”), dated as of September 25, 2025, among the Company, as a borrower, Sanuwave, Inc., as a guarantor, the lenders

Read the filing on SEC EDGAR →

What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Every item ranked →

What this kind of filing means

Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.

Sanuwave Health at a glance

Latest quarterQ2 2026
Revenue$9.7M
Revenue Y/Y-3%
Operating margin-2.9%
IndustrySurgical & Medical Instruments & Apparatus

Sanuwave Health, Q2 2026: revenue $9.7M (-3% year over year), operating margin -2.9%. The chart follows the revenue to costs, profit and cash.

Sanuwave Health: every quarter, Q/Q and Y/Y, holders and guidance →

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.